Back to Search
Start Over
Population Pharmacokinetic Analysis of Fevipiprant in Healthy Subjects and Asthma Patients using a Tukey’s g-and-h Distribution.
- Source :
-
Drug research [Drug Res (Stuttg)] 2021 Jul; Vol. 71 (6), pp. 326-334. Date of Electronic Publication: 2021 Mar 05. - Publication Year :
- 2021
-
Abstract
- Competing Interests: All the authors are Novartis employees. The authors report no other conflict of interest in this work.
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Asthma drug therapy
Biological Variation, Population
Child
Clinical Trials, Phase I as Topic
Clinical Trials, Phase III as Topic
Dose-Response Relationship, Drug
Female
Healthy Volunteers
Humans
Indoleacetic Acids administration & dosage
Indoleacetic Acids adverse effects
Male
Middle Aged
Multicenter Studies as Topic
Pyridines administration & dosage
Pyridines adverse effects
Randomized Controlled Trials as Topic
Receptors, Immunologic antagonists & inhibitors
Receptors, Prostaglandin antagonists & inhibitors
Young Adult
Asthma blood
Indoleacetic Acids pharmacokinetics
Models, Biological
Pyridines pharmacokinetics
Subjects
Details
- Language :
- German
- ISSN :
- 2194-9387
- Volume :
- 71
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Drug research
- Publication Type :
- Academic Journal
- Accession number :
- 33682912
- Full Text :
- https://doi.org/10.1055/a-1381-6579